Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

FDA Approves Generic Lutathera for Adults With GEP-NETs

Bexlutry is the first radioligand equivalent approved by the agency for treatment of the rare tumors.

Body-Related TikTok Reels Tied to Self-Objectification, Mood

Viewing appearance-focused TikTok videos is associated with increased self-objectification in women, as well as changes in mood.

Could Psilocybin Prevent Nerve Damage From Chemotherapy?

Preclinical findings suggest that psilocybin may protect sensory nerves from chemotherapy toxicity, but clinical trials are still needed to determine whether it benefits patients.

Report Backs Proactive Pediatric-Adult Diabetes Care Handoff

International consensus from three societies recommends planning the transition for youth with diabetes at least 1-2 years in advance.

Waist Size, Not Just BMI, Predicts Mortality in Older Adults

Adults aged 65 years or older with a higher waist circumference face a notably higher risk for all-cause mortality even at a normal BMI, according to a 14-year US cohort study.

FDA Okays Finerenone for CKD in Adults With Type 1 Diabetes

It is the first new treatment in more than 30 years approved for treating chronic kidney disease in T1D.

Todays Updates

Annual Cancer Report Highlights Advances, Funding Threats

A yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.

Does Telenursing Improve QOL in Breast Cancer?

A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.

Long-Term Results Favor Acalabrutinib Combo in MCL

The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.

Todays Updates

Annual Cancer Report Highlights Advances, Funding Threats

A yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.

Does Telenursing Improve QOL in Breast Cancer?

A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.

Long-Term Results Favor Acalabrutinib Combo in MCL

The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.

Latest News

Bexlutry is the first radioligand equivalent approved by the agency for treatment of the rare tumors.

Viewing appearance-focused TikTok videos is associated with increased self-objectification in women, as well as changes in mood.

Preclinical findings suggest that psilocybin may protect sensory nerves from chemotherapy toxicity, but clinical trials are still needed to determine whether it benefits patients.

International consensus from three societies recommends planning the transition for youth with diabetes at least 1-2 years in advance.

Adults aged 65 years or older with a higher waist circumference face a notably higher risk for all-cause mortality even at a normal BMI, according to a 14-year US cohort study.

It is the first new treatment in more than 30 years approved for treating chronic kidney disease in T1D.

News All Time

Food Tracking for Weight Loss: More Tracking, More Loss

In a study of 5132 app users, higher food tracking frequency was associated with greater weight loss, with more than 70% losing at least 5% of their body weight at 6 months.

Dysesthesia Risk Appears to Rise With GLP-1s

A meta-analysis suggests that GLP-1 drugs may raise the risk for dysesthesia, with greater weight loss potentially linked to a higher risk.

Thyroid, Other Autoimmune Issues Tied to Fertility Decline

Women with thyroid autoimmunity plus other autoimmune conditions have a nearly 6% rate of premature ovarian insufficiency, which is fivefold higher than that of those without autoimmune disorders.

FDA Clears New Type of Insulin Patch Pump From Beta Bionics

The company anticipates its two pumps will work with a next-generation insulin dosing algorithm.

Endocrine Society Launches New Initiatives Around Obesity

A new scientific statement was published and Center on Obesity was launched simultaneously.

New Guidance Addresses Diabetes and Smoking Cessation

The issue is underemphasized in clinical diabetes care, authors say.

Retatrutide: It’s Already in Your Waiting Room

Social media has triggered a retatrutide tsunami. What can clinicians do when patients disclose taking an unapproved weight-loss drug?

Whole-Plant Extract Outperforms THC on Glycemia

Whole-plant cannabis extract beats THC alone at improving glucose control in obese mice. Here's what the science means for patient conversations.

Novo Nordisk Says Wegovy Approved in China for MASH

Denmark's Novo Nordisk ⁠said on Thursday its blockbuster ⁠weight-loss drug Wegovy had ⁠been approved ‌in China as the first GLP-1 RA class of drugs for the ‌treatment of MASH.

Diabetes Care in Danish Care Homes May Miss the Mark

About 1 in 8 Danish care home residents with T2D admitted from 2018 to 2023 used glucose-lowering drugs, and most continued treatment despite having A1c levels below recommended targets.

Weekly Basal Insulin + Semaglutide Combo May Benefit T2D

Novo Nordisk’s phase 3b trial shows once-weekly IcoSema improves glycemic control and weight with less hypoglycemia than insulin glargine U100 in adults with type 2 diabetes.

Menopausal Symptoms Worse in Women With Type 2 Diabetes

An observational study finds a higher number of symptoms and greater severity among midlife women with type 2 diabetes than among those without.

High Semaglutide Dropout Rates Signal Adherence Challenge

With nearly half of patients discontinuing semaglutide within 12 months — especially younger adults — clinicians face a growing challenge in sustaining long-term treatment.

Obesity Rises Faster in Young Adults, Steeper in Older Adults

Obesity is increasing faster among young adults worldwide, even as older adults still carry the greater overall burden, a new analysis of 196 countries over three decades finds.

Soccer-Spanish FA Launches Fertility Support Programme for Female Players and Referees

Spain's football federation has unveiled an agreement to support fertility treatment for female players and referees, presenting the measure as another way to give women in...

Midwifery Goes Beyond Birth: What Is Still Overlooked?

Midwives’ roles extend across reproductive, pregnancy, postpartum, pelvic floor, and community care, but cultural, structural, and professional barriers can limit their practice.

Recommended News For You

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

Definium's LSD-based Anxiety, Depression Drug Scores Another Trial Win

Study: Discovery of cellular identity may influence cancer treatment

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Rewriting the Future of Medicine; Cancer Cost Burden; Mental Health Toll of Cancer

Cancer After Weight Loss; How Older Adults Use the Healthcare System.

Eight Doctors Killed in Brazil's Horrifying Plane Crash

Recommended Articles For You

Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma 

Hypercoagulable State: Factors that Contribute to Blood Clots  

AI in the War on Cancer: How Digital Tools are Revolutionizing Oncology 

Individualized Hematopoietic Reserve Assessment in Blood Disorders 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Accuracy of Skin Cancer Diagnosis Varies by Physician, Exam Method

2.

From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.

3.

GLP-1 Receptor antagonists used in a study allay fears about thyroid cancer.

4.

Psychotropics Linked to Increased BMI, CVD Risk

5.

Discovery of a new biomarker for early detection of bladder cancer in both dogs and humans

1.

Uncovering Breast Cancer: The Power of Early Stage Ultrasound

2.

Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights

3.

AI in Cancer Diagnostics and Imaging Interpretation

4.

Virtual Oncology Follow-Up: Current Practices, Evidence, and Clinical Implications

5.

The Life-Saving Powers of Anemia: How to Combat the Disease.

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

2.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

3.

Managing Common Side Effects During Cancer Treatment

4.

How Platelet Disorders Can Affect the Body

5.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot